Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
Nadia Bouattour, Olfa Hdiji, Salma Sakka, Emna Fakhfakh, Khadija Sonda Moalla, Sawsan Daoud, Nouha Farhat, Mariem Damak, Chokri Mhiri
Topics & Concepts
MedicineElectromyoneurographyNeurologyGuillain-Barre syndromePolyradiculoneuropathyVaccinationPediatricsPandemicCoronavirus disease 2019 (COVID-19)WeaknessNeurosurgeryDemyelinating DisorderAcute disseminated encephalomyelitisSurgeryImmunologyDiseaseInternal medicineInfectious disease (medical specialty)PsychiatryPeripheral Neuropathies and DisordersLong-Term Effects of COVID-19Multiple Sclerosis Research Studies